克洛扎诱导的肝毒性:病例报告和简要的回顾
Joshep Revilla-Zúñiga1, Joise Cornejo-Del Carpio2, Lizardo Cruzado1
1Instituto Nacional de Salud Mental Honorio Delgado-Hideyo Noguchi, Lima, Peru; Universidad Peruana Cayetano Heredia, Lima, Peru.
Revista Colombiana de psiquiatria (English ed.)
|July 17, 2023
概括
克洛沙平是一种治疗精神分裂症的抗精神病药物,可导致肝损伤. 这一案例突显了克洛扎诱导的肝毒性致命的结果,强调了需要仔细监测的必要性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 抗精神病药可以导致肝酶的暂时升高.
- 克洛扎宾是一种非典型的抗精神病药物,用于治疗耐药精神分裂症.
- 有证据表明,克洛扎平可以提高肝脏的转氨基酶,这表明肝细胞肝脏受损.
研究的目的:
- 报告一个致命的克洛扎诱导的肝毒性病例.
- 审查关于克洛扎和肝损伤的文献.
主要方法:
- 一个患有精神分裂症的病人用克洛札治疗的病例报告.
- 相关医学文献的非系统性审查.
主要成果:
- 一名39岁的妇女在开始服用克洛扎平后出现恶心,吐和黄.
- 患者没有经历临床改善,并在44天后死亡.
- 这是据报道的第三起克洛扎诱导的肝毒性致死病例.
结论:
- 克洛沙平可以引起暂时且无症状的肝酶升高.
- 由于肝酶升高,对于停止使用克洛扎宾存在临床标准.
- 致死性肝毒性是一种罕见但严重的克洛札不良反应.
相关概念视频
Psychosis: Goals of Pharmacotherapy
170
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
170
Drug Therapy
73
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
73
Hepatic Drug Excretion: Influencing Factors
158
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
158
Psychosis and Antipsychotic Drugs: Overview
336
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
336
Hepatic Drug Clearance: Effect of Protein Binding
249
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
249
Hepatic Drug Clearance: Role of Transporters
87
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
87


